ACS Omega (2024) 9(22):2357383
Alternative metrics: when BMI is not the whole story BMI is the gatekeeper, but it is not the only measure of whether you would benefit from GLP-1 therapy
One study even shows that luminal A/B breast cancer patients with high IGF-IR and negative EGFR expression have better prognosis than the rest [40]
Look for patterns of lower-than-usual readings, especially between meals or in the early morning
As described in this manuscript, the relationship between SGLT2 inhibitors and systolic BP is clear, with this reduction in BP potentially improving cardiovascular outcomes
The emotional reactions to semaglutide reveal an uncomfortable truth: yes, excessive attachment to desires causes suffering (obesity as a disease, addiction, depression)